{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:24:14Z","timestamp":1787739854395,"version":"build-2784847793"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["AHEAD-DBG-23-1156429-01-MM"],"award-info":[{"award-number":["AHEAD-DBG-23-1156429-01-MM"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017982","name":"Illinois Society for the Prevention of Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["R01EY029339"],"award-info":[{"award-number":["R01EY029339"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013779","name":"Retina Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010264","name":"Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY001792"],"award-info":[{"award-number":["EY001792"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY031350"],"award-info":[{"award-number":["EY031350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ajpath.2025.05.022","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:06:45Z","timestamp":1750792005000},"page":"1736-1754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Activin A Prevents Hyperresponsiveness to Vascular Endothelial Growth Factor in Pathologic Blood Vessels by Perturbing the Trafficking of Activated Vascular Endothelial Growth Factor Receptor 2"],"prefix":"10.1016","volume":"195","author":[{"given":"Basma","family":"Baccouche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8661-430X","authenticated-orcid":false,"given":"Maximilian","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janani","family":"Rajasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguy\u1ec5n Th\u1ecb Thanh","family":"Nh\u00e0n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1919-3327","authenticated-orcid":false,"given":"Andrius","family":"Kazlauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2025.05.022_bib1","doi-asserted-by":"crossref","first-page":"H738","DOI":"10.1152\/ajpheart.00005.2016","article-title":"Neurovascular cross talk in diabetic retinopathy: pathophysiological roles and therapeutic implications","volume":"311","author":"Moran","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajpath.2025.05.022_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1874364101307010004","article-title":"Diabetic retinopathy and VEGF","volume":"7","author":"Gupta","year":"2013","journal-title":"Open Ophthalmol J"},{"key":"10.1016\/j.ajpath.2025.05.022_bib3","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2025.05.022_bib4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2025.05.022_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2337\/dc13-2002","article-title":"Ocular anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy","volume":"37","author":"Sim\u00f3","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpath.2025.05.022_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajpath.2012.06.006","article-title":"A brief history of anti-VEGF for the treatment of ocular angiogenesis","volume":"181","author":"Kim","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2025.05.022_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cell.2007.06.054","article-title":"Iruela-Arispe ML: Autocrine VEGF signaling is required for vascular homeostasis","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2025.05.022_bib8","first-page":"2115","article-title":"Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes","volume":"40","author":"Kim","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2025.05.022_bib9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1083\/jcb.135.4.913","article-title":"Rab11 regulates recycling through the pericentriolar recycling endosome","volume":"135","author":"Ullrich","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2025.05.022_bib10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1182\/blood-2011-01-328773","article-title":"Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output","volume":"118","author":"Ballmer-Hofer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2025.05.022_bib11","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1074\/jbc.M117.812172","article-title":"The Rab-effector protein RABEP2 regulates endosomal trafficking to mediate vascular endothelial growth factor receptor-2 (VEGFR2)-dependent signaling","volume":"293","author":"Kofler","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2025.05.022_bib12","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/ATVBAHA.114.303217","article-title":"Receptor tyrosine kinases endocytosis in endothelium: biology and signaling","volume":"34","author":"Zhang","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2025.05.022_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.phrs.2016.11.022","article-title":"Modulation of VEGF receptor 2 signaling by protein phosphatases","volume":"115","author":"Corti","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ajpath.2025.05.022_bib14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s44161-022-00064-2","article-title":"Syndecan-2 selectively regulates VEGF-induced vascular permeability","volume":"1","author":"Corti","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.ajpath.2025.05.022_bib15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1083\/jcb.200209019","article-title":"Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1\/CD148","volume":"161","author":"Grazia Lampugnani","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2025.05.022_bib16","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1096\/fj.08-123810","article-title":"Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis","volume":"23","author":"Mellberg","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2025.05.022_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.tcb.2010.08.013","article-title":"In control at the ER: PTP1B and the down-regulation of RTKs by dephosphorylation and endocytosis","volume":"20","author":"Stuible","year":"2010","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.ajpath.2025.05.022_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2025.05.022_bib19","doi-asserted-by":"crossref","first-page":"15859","DOI":"10.1073\/pnas.2136855100","article-title":"Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo","volume":"100","author":"Shih","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2025.05.022_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41569-021-00517-4","article-title":"The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy","volume":"18","author":"Ricard","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ajpath.2025.05.022_bib21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34423","article-title":"The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium","volume":"7","author":"Schlereth","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.ajpath.2025.05.022_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/scd.2023.0003","article-title":"Notch pathways regulate expression of angiostatic factor activin A in endothelial\u2013pericyte-like mesenchymal stromal cell interactions","volume":"32","author":"Merfeld-Clauss","year":"2023","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.ajpath.2025.05.022_bib23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/emboj\/cdg156","article-title":"Structures of an ActRIIB:activin a complex reveal a novel binding mode for TGF-[beta] ligand:receptor interactions","volume":"22","author":"Thompson","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.ajpath.2025.05.022_bib24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/dvg.22352","article-title":"Generation of a conditional mouse model to target Acvr1b disruption in adult tissues","volume":"51","author":"Ripoche","year":"2013","journal-title":"Genesis"},{"key":"10.1016\/j.ajpath.2025.05.022_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108698","article-title":"Activin A limits VEGF-induced permeability via VE-PTP","volume":"24","author":"Baccouche","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2025.05.022_bib26","article-title":"The slow progression of diabetic retinopathy is associated with transient protection of retinal vessels from death","volume":"24","author":"Li","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"203","key":"10.1016\/j.ajpath.2025.05.022_bib27","doi-asserted-by":"crossref","DOI":"10.3791\/66123","article-title":"An assay to detect protection of the retinal vasculature from diabetes-related death in mice","author":"Li","year":"2024","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ajpath.2025.05.022_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092431","article-title":"The multi-kinase inhibitor repsox enforces barrier function in the face of both VEGF and cytokines","volume":"11","author":"Lietuvninkas","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajpath.2025.05.022_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00018-023-04752-5","article-title":"KIF13B mediates VEGFR2 recycling to modulate vascular permeability","volume":"80","author":"Cho","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ajpath.2025.05.022_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076402","article-title":"VEGF induces expression of genes that either promote or limit relaxation of the retinal endothelial barrier","volume":"24","author":"McCann","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2025.05.022_bib31","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.cell.2020.08.013","article-title":"Cell types of the human retina and its organoids at single-cell resolution","volume":"182","author":"Cowan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2025.05.022_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12859-024-05889-1","article-title":"RankCompV3: a differential expression analysis algorithm based on relative expression orderings and applications in single-cell RNA transcriptomics","volume":"25","author":"Yan","year":"2024","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ajpath.2025.05.022_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108718","article-title":"Single cell RNA sequencing (scRNA-Seq) deciphering pathological alterations in streptozotocin-induced diabetic retinas","volume":"210","author":"Sun","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajpath.2025.05.022_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ajpath.2025.05.022_bib35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.devcel.2013.08.020","article-title":"VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity","volume":"26","author":"Giannotta","year":"2013","journal-title":"Dev Cell"},{"key":"10.1016\/j.ajpath.2025.05.022_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31037","article-title":"YAP and TAZ regulate adherens junction dynamics and endothelial cell distribution during vascular development","volume":"7","author":"Neto","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.ajpath.2025.05.022_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49646-4","article-title":"Regulation of VEGFR2 trafficking and signaling by Rab GTPase-activating proteins","volume":"9","author":"Xie","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2025.05.022_bib38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10456-021-09788-4","article-title":"The endosomal RIN2\/Rab5C machinery prevents VEGFR2 degradation to control gene expression and tip cell identity during angiogenesis","volume":"24","author":"Kempers","year":"2021","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ajpath.2025.05.022_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the dependency of cellular protein levels on MRNA abundance","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2025.05.022_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.29154","article-title":"Site-specific monoubiquitination downregulates Rab5 by disrupting effector binding and guanine nucleotide conversion","volume":"6","author":"Shin","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.ajpath.2025.05.022_bib41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41433-021-01825-2","article-title":"Perspectives on diabetic retinopathy from advanced retinal vascular imaging","volume":"36","author":"Ong","year":"2022","journal-title":"Eye"},{"key":"10.1016\/j.ajpath.2025.05.022_bib42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4239\/wjd.v6.i3.489","article-title":"Diabetic retinopathy - ocular complications of diabetes mellitus","volume":"6","author":"Nentwich","year":"2015","journal-title":"World J Diabetes"},{"key":"10.1016\/j.ajpath.2025.05.022_bib43","doi-asserted-by":"crossref","first-page":"892","DOI":"10.7150\/ijbs.24548","article-title":"Identifying differentially expressed genes from cross-site integrated data based on relative expression orderings","volume":"14","author":"Cai","year":"2018","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ajpath.2025.05.022_bib44","first-page":"222","article-title":"Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice","volume":"42","author":"Brooks","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2025.05.022_bib45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0021-5155(99)00216-6","article-title":"Expression and possible roles of activin A in proliferative vitreoretinal diseases","volume":"44","author":"Yamamoto","year":"2000","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ajpath.2025.05.022_bib46","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3390\/cells11152336","article-title":"TGF-beta superfamily signaling in the eye: implications for ocular pathologies","volume":"11","author":"Hachana","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2025.05.022_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2024-004189","article-title":"Single-cell transcriptomic analysis reveals the antiangiogenic role of Mgarp in diabetic retinopathy","volume":"12","author":"Ren","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.ajpath.2025.05.022_bib48","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1242\/dmm.009597","article-title":"Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals","volume":"5","author":"Robinson","year":"2012","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.ajpath.2025.05.022_bib49","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1167\/iovs.18-25372","article-title":"Longitudinal in vivo characterization of the streptozotocin-induced diabetic mouse model: focus on early inner retinal responses","volume":"60","author":"Sergeys","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2025.05.022_bib50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0079-6107(98)00047-9","article-title":"Structural analysis of receptor tyrosine kinases","volume":"71","author":"Hubbard","year":"1999","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.ajpath.2025.05.022_bib51","doi-asserted-by":"crossref","first-page":"10262","DOI":"10.1016\/S0021-9258(19)81508-9","article-title":"Continuous internalization of tumor necrosis factor receptors in a human myosarcoma cell line","volume":"263","author":"Watanabe","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2025.05.022_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cytogfr.2016.07.002","article-title":"Endocytic regulation of cytokine receptor signaling","volume":"32","author":"Cendrowski","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ajpath.2025.05.022_bib53","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrm2430","article-title":"Regulation of TNFR1 and CD95 signalling by receptor compartmentalization","volume":"9","author":"Sch\u00fctze","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2025.05.022_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2007\/95103","article-title":"Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy","volume":"2007","author":"Kern","year":"2007","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.ajpath.2025.05.022_bib55","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.freeradbiomed.2003.08.018","article-title":"Hyperglycemia increases mitochondrial superoxide in retina and retinal cells","volume":"35","author":"Du","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ajpath.2025.05.022_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/dmr.5610110203","article-title":"Retinopathy in animal models of diabetes","volume":"11","author":"Engerman","year":"1995","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.ajpath.2025.05.022_bib57","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.21037\/atm-20-6737","article-title":"Animal models of diabetic retinopathy","volume":"9","author":"Quiroz","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ajpath.2025.05.022_bib58","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1152\/jn.00761.2014","article-title":"Early retinal pigment epithelium dysfunction is concomitant with hyperglycemia in mouse models of type 1 and type 2 diabetes","volume":"113","author":"Samuels","year":"2015","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.ajpath.2025.05.022_bib59","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1074\/mcp.M115.053249","article-title":"Quantitative proteomics reveals [beta]2 integrin-mediated cytoskeletal rearrangement in vascular endothelial growth factor (VEGF)-induced retinal vascular hyperpermeability\u2217","volume":"15","author":"Jo","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ajpath.2025.05.022_bib60","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/sj.eye.6700133","article-title":"The pathogenesis of diabetic retinopathy: old concepts and new questions","volume":"16","author":"Cai","year":"2002","journal-title":"Eye"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025002081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025002081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:16:39Z","timestamp":1778634999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944025002081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0002944025002081"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.05.022","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activin A Prevents Hyperresponsiveness to Vascular Endothelial Growth Factor in Pathologic Blood Vessels by Perturbing the Trafficking of Activated Vascular Endothelial Growth Factor Receptor 2","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}